INVERSE RELATION OF 25-OH VITAMIN D LEVEL WITH SEVERITY OF DIABETIC RETINOPATHY AND HBA1C IN TYPE 2 DIABETES PATIENTS: SUPPLEMENTATION MAY HALT SEVERITY

CHHAYA VERMA

doi:10.22159/ajpcr.2024.v17i3.50579

Authors

CHHAYA VERMA Department of Ophthalmology, Mahamaya Rajkiya Allopathic Medical College, Ambedkar Nagar, Uttar Pradesh, India

DOI:

https://doi.org/10.22159/ajpcr.2024.v17i3.50579

Keywords:

Diabetic retinopathy, HbA1c, 25-OH vitamin D, NPDR, PDR, PTH

Abstract

Objective: Our aim was to analyze the relationship of 25-OH Vitamin D level with severity of diabetic retinopathy (DR) and HbA1c in Type 2 diabetes patients.

Methods: In the present observational study, we enrolled 140 cases of type 2 diabetic patients (98 with DR and 42 without DR). A complete ophthalmological evaluation was done. 25-OH vitamin D levels were compared with the severity of DR and HbA1c levels. The serum concentration of 25-hydroxyl vitamin D was measured by the radioimmunoassay method. Vitamin D deficiency was considered when the 25-hydroxyl vitamin D level was <20 ng/mL.

Results: There was no significant difference in age, sex, calcium, parathyroid hormone, and phosphate levels between groups. Sixty-nine out of 98 patients with retinopathy and 15 out of 42 without retinopathy had a 25-hydroxyl vitamin D level <20 ng/mL. DR patients have a higher proportion of subjects with vitamin D deficiency as compared to those without DR (p=0.045). We also found a significant inverse correlation between serum 25- OH vitamin D and severity of DR on ANOVA and HbA1c levels (p<0.001) on Pearson’s correlation.

Conclusion: 25-OH vitamin D deficiency is associated with DR and increased HbA1c levels. Vitamin D supplementation with good blood sugar control may decrease the severity of DR in type 2 diabetes. All patients with type 2 diabetes mellitus, besides undergoing fundoscopic examinations, must be assessed for their vitamin D status.

Downloads

Download data is not yet available.

References

Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond) 2015;2:17.

Das T, Aurora A, Chhablani J, Giridhar A, Kumar A, Raman R, et al. Evidence-based review of diabetic macular edema management. Consensus statement on Indian treatment guidelines. Indian J Ophthalmol 2016;64:14-25.

Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 2008;10:185-97.

Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: The calcium and Vitamin D for diabetes mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 2011;94:486-94.

Lokesh S, Shivaswamy S. Study of HbA1C levels in patients with type 2 diabetes mellitus in relation to diabetic retinopathy in Indian population. Int J Adv Med 2018;5:1397-401.

Luo BA, Gao F, Qin LL. The association between vitamin D deficiency and diabetic retinopathy in type 2 diabetes: A meta-analysis of observational studies. Nutrients 2017;9:307.

Suzuki A, Kotake M, Ono Y, Kato T, Oda N, Hayakawa N, et al. Hypovitaminosis D in type 2 diabetes mellitus: Association with microvascular complications and type of treatment. Endocr J 2006;53:503-10.

Payne JF, Ray R, Watson DG, Delille C, Rimler E, Cleveland J, et al. Vitamin D insufficiency in diabetic retinopathy. Endocr Pract 2012;18:185-93.

Giacomo Z, Galletti A, Targher G, Brangani C, Pichiri I, Negri C, et al. Glycated haemoglobin is inversely related to serum vitamin D levels in type 2 diabetic patients. PLoS One 2013;8:e82733.

Jee D, Han KD, Kim EC. Inverse association between high blood 25-hydroxyvitamin D levels and diabetic retinopathy in a representativeKorean population. PLoS One 2014;9:e115199.

Von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomised, placebo-controlled trial. Br J Nutr 2010;103:549-55.

Alsalem JA, Patel D, Susarla R, Bland R, Walker EA, Rauz S, et al. Characterization of vitamin D production by human ocular barrier cells. Invest Ophthalmol Vis Sci 2014;55:2140-7.

Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE. 1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res 2000;87:214-20.